<Suppliers Price>

5-(N-Methyl-N-isobutyl)-Amiloride

Names

[ CAS No. ]:
96861-65-3

[ Name ]:
5-(N-Methyl-N-isobutyl)-Amiloride

[Synonym ]:
5-(N-Methyl-N-isobutyl)amiloride
Methylisobutylamiloride
MFCD00078567
Lopac-A-5585
5-Nmnia
3-amino-6-chloro-n-(diaminomethylene)-5-[isobutyl(methyl)amino]pyrazine-2-carboxamide

Chemical & Physical Properties

[ Density]:
1.49g/cm3

[ Boiling Point ]:
543.9ºC at 760mmHg

[ Melting Point ]:
200-201 °C

[ Molecular Formula ]:
C11H18ClN7O

[ Molecular Weight ]:
299.76000

[ Flash Point ]:
282.8ºC

[ Exact Mass ]:
299.12600

[ PSA ]:
134.01000

[ LogP ]:
2.34230

[ Index of Refraction ]:
1.664

MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
36/37/38

[ Safety Phrases ]:
26-36

[ RIDADR ]:
UN 2811

[ Packaging Group ]:
III

[ Hazard Class ]:
6.1(b)

Articles

Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer.

Int. J. Oncol. 46(4) , 1788-800, (2015)

We have generated a novel monoclonal antibody (mAb), OCAb9-1, which specifically binds to various types of cancer cell lines, but not to normal cells. According to the results of immunoaffinity chroma...

Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer.

Cancer Biol. Ther. 16(3) , 438-49, (2015)

Tumors often contain hypoxic regions resistant to chemo- and radiotherapy. TH-302 (T) is an investigational hypoxia-activated prodrug that selectively releases the DNA cross-linker bromo-isophosphoram...

Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation.

Nat. Commun. 6 , 6426, (2015)

Cancer research relies heavily on murine models for evaluating the anti-tumour efficacy of therapies. Here we show that the sensitivity of several pancreatic tumour models to cytotoxic therapies is si...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.